6-Methoxy-2-azaspiro[3.3]heptane hydrochloride, 97%, 1g

N-Methoxy-N-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 95.0%, 250mg

TRANS-(3-FLUOROCYCLOPENTYL)METHANAMINE HCL, 95.0%, 250mg

GC capillary column ROTI®Cap-624, 50 m, 0.32 mm, 1.80 µm, 1 Piece(s)

6-Bromochroman-2-one, 95.0%, 10g

4,7,10,13,16-Pentaoxanonadeca-1,18-diyne, 98%, 5g

2-(4-Chloro-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

3-Bromo-5'-phenyl-1,1':3',1''-terphenyl, 95.0%, 250mg

4-(2-Morpholinoethyl)aniline, 95.0%, 25g

4-(azidomethyl)benzoic acid, 95.0%, 500mg

3-Iodobenzhydrazide, 95%, 10g

4-Methyl-3-oxo-N-phenylpentanamide, 95.0%, 100g

(2S,3S,4R,5R)-5-(2-Chloro-6-((3-iodobenzyl)amino)-9H-purin-9-yl)-3,4-dihydroxy-N-methyltetrahydrofuran-2-carboxamide, 99+%, 100mg